Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Miravant and Bausch & Lomb to review SnET2 data with license option

June 13, 2002

Positive phase III results announced for ophthalmic implant for diabetic macular edema

June 12, 2002

CPMP recommends approval of Visudyne in occult subfoveal CNV secondary to AMD

June 3, 2002

Japanese labs identify new antiglaucoma agents

May 15, 2002

U.S. researchers successfully design soft cannabinoid analogues with potential in glaucoma Rx

May 14, 2002

Adenoviral gene transfer of PEDF inhibits choroidal neovascularization in animal models

May 9, 2002

Cannabinoid agonist reduces IOP by decreasing aqueous humor flow

May 9, 2002

Rights to angiotensin II receptor blocker for glaucoma licensed to Santen

May 9, 2002

Squalamine reported to have beneficial effects in animal model of wet AMD

May 8, 2002

Sustained transcleral delivery of EYE-001 achieved using PLGA microspheres

May 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...